FIKKAN PHARMA AS

0586 OSLO

Finances

Return on Equity

22,02 %

Current Ratio

4,28

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	668 000	346 000	308 000	379 000
Net Income	410 000	143 000	412 000	202 000
Total Assets	2 097 000	1 597 000	1 435 000	1 056 000
Total Equity	1 862 000	1 453 000	1 310 000	898 000

Income (NOK)	2022	2021	2020	2019
Revenue	668 000	346 000	308 000	379 000
Expenditure	144 000	158 000	85 000	120 000
Operating Profit	524 000	188 000	224 000	259 000
Financial Income	1 000	0	239 000	0
Financial Costs	0	4 000	1 000	1 000
Financial Balance	1 000	−4 000	238 000	−1 000
Earnings Before Tax	525 000	184 000	462 000	259 000
Tax	116 000	41 000	49 000	57 000
Net Income	410 000	143 000	412 000	202 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 096 000	1 043 000	1 068 000	631 000
Total Current Assets	1 001 000	554 000	366 000	424 000
Total Assets	2 097 000	1 597 000	1 435 000	1 056 000
Total Retained Equity	1 832 000	1 423 000	1 280 000	868 000
Total Equity	1 862 000	1 453 000	1 310 000	898 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	234 000	145 000	125 000	158 000
Total Equity and Debt	2 097 000	1 597 000	1 435 000	1 056 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	668 000	346 000	308 000	379 000
Other Income	0	0	0	0
Revenue	668 000	346 000	308 000	379 000
Cost of Goods Sold	50 000	65 000	7 000	11 000
Salary Costs	0	0	0	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	144 000	158 000	85 000	120 000
Operating Profit	524 000	188 000	224 000	259 000
Financial Income	1 000	0	239 000	0
Financial Costs	0	4 000	1 000	1 000
Financial Balance	1 000	−4 000	238 000	−1 000
Dividends	0	0	0	0
Net Income	410 000	143 000	412 000	202 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	26 000	26 000	26 000	26 000
Total Tangible Assets	26 000	26 000	26 000	26 000
Total Fiancial Fixed Assets	1 070 000	1 018 000	1 043 000	606 000
Total Fixed Assets	1 096 000	1 043 000	1 068 000	631 000
Stock	91 000	82 000	39 000	46 000
Total Investments	0	0	0	0
Cash, Bank	809 000	369 000	323 000	332 000
Total Current Assets	1 001 000	554 000	366 000	424 000
Total Assets	2 097 000	1 597 000	1 435 000	1 056 000
Total Equity	1 862 000	1 453 000	1 310 000	898 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	1 000	70 000	0	1 000
Unpaid Taxes	118 000	24 000	63 000	77 000
Dividends	0	0	0	0
Other Current Debt	0	11 000	13 000	23 000
Total Current Debt	234 000	145 000	125 000	158 000
Total Equity and Debt	2 097 000	1 597 000	1 435 000	1 056 000

Financial indicators	2022	2021	2020	2019
Return on Equity	22,02 %	9,84 %	31,45 %	22,49 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	78,44 %	54,34 %	72,73 %	68,34 %
Current Ratio	4,28	3,82	2,93	2,68
Quick Ratio	7	8,79	4,26	3,79
Equity Ratio	0,89	0,91	0,91	0,85
Gross Profit Margin	92,51 %	81,21 %	97,73 %	97,1 %